Abstract
Sickle cell anemia patients present challenges and complexities in resolving immunohematology testing which can lead to severe transfusion complications. Solve it!
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Reference
Centers for Disease Control and Prevention. National healthcare safety network biovigilance component, hemovigilance module surveillance protocol v2.6, Atlanta, GA. March 2021. Available from: https://www.cdc.gov/nhsn/PDFs/Biovigilance/BV-HV-protocol-current.pdf Accessed 4 Jan 2022.
Further Reading
Klein HG, Anstee DJ. Haemolytic transfusion reactions. In: Klein HG, Anstee DJ, editors. Mollison’s blood transfusion in clinical medicine. 12th ed. West Sussex: Wiley; 2014. p. 472.
Win N, Doughty H, Telfer P, Wild BJ, Pearson TC. Hyperhemolytic transfusion reaction in sickle cell disease. Transfusion. 2001;41(3):323–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Friedman, M.T., West, K.A., Bizargity, P., Annen, K., Gur, H.D., Hilbert, T. (2023). The Perils of Transfusing the Sickle Cell Patient. In: Immunohematology, Transfusion Medicine, Hemostasis, and Cellular Therapy. Springer, Cham. https://doi.org/10.1007/978-3-031-14638-1_63
Download citation
DOI: https://doi.org/10.1007/978-3-031-14638-1_63
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-14637-4
Online ISBN: 978-3-031-14638-1
eBook Packages: MedicineMedicine (R0)